The most comprehensive diabetes knowledge base online. Understand your diabetes. Know your supplies. Make better decisions.
MDS Diabetes
Diabetes
Encyclopedia
Shop Supplies β†’
Researchβœ“ Reviewed for accuracy

CGM Data May Predict Pregnancy Risks in Type 1 Diabetes

A new study found that CGM readings in the late second trimester may help predict serious pregnancy complications in women with type 1 diabetes.

M
MDS Diabetes Team
Β·6 min read
𝕏f
Key takeaways
  • βœ“In pregnant women with type 1 diabetes, CGM metrics between weeks 28 and 30 showed the strongest link to high blood pressure disorders and large babies β€” suggesting this window is critical for tightening glucose control.
Quick specs
JournalJournal of diabetes science and technology
Year2026
AuthorsFisher, Pavan, Villa-Tamayo
PMID41186140
DOI10.1177/19322968251388119

What This Study Found

Researchers looked at continuous glucose monitor (CGM) data from 87 pregnant women with type 1 diabetes. They found that blood sugar patterns in the late second trimester β€” especially around weeks 28 to 30 β€” were strongly linked to serious pregnancy complications. Women whose CGM data showed more time above the target blood sugar range were more likely to develop high blood pressure problems or have a larger-than-normal baby.

Why This Matters for You

Pregnancy with type 1 diabetes comes with real risks β€” for both mom and baby. This study highlights that what your blood sugar looks like around weeks 28 to 30 of pregnancy may be one of the most important warning signs of problems ahead.

Three outcomes were studied:

  • Hypertensive disorders of pregnancy (HDP) β€” like preeclampsia, which can be dangerous for both mother and baby
  • Large-for-gestational-age (LGA) babies β€” when a baby grows too large, which can complicate delivery
  • Neonatal hypoglycemia β€” low blood sugar in the newborn after birth

Importantly, 71% of the women in this study experienced at least one of these complications β€” even though their average A1C before pregnancy was a relatively well-controlled 6.5%. That tells us A1C alone doesn't capture the full picture. How blood sugar moves throughout the day β€” and especially how much time is spent above range β€” matters deeply during pregnancy.

What the CGM Data Showed

Women who developed high blood pressure disorders had higher average blood sugar and spent more time above the target range (above 140 mg/dL) compared to those who didn't. Women who had larger babies tended to have less time below range (below 63 mg/dL) during weeks 24 to 35.

The biggest differences between groups appeared at weeks 28 to 30 β€” a time when the body naturally becomes more resistant to insulin. This is a known challenge in pregnancy, but the study suggests it's also a key opportunity to intervene.

What This Means Practically

If you have type 1 diabetes and are pregnant β€” or planning to become pregnant β€” this research supports the value of wearing a CGM throughout your pregnancy. CGM gives you and your care team a real-time, detailed picture of your blood sugar that an A1C test simply cannot provide.

Knowing that the late second trimester is a critical window means your doctor may want to review your CGM data more closely during that time and make adjustments to your insulin doses or meal plan.

MDS Diabetes carries a range of CGM supplies and diabetes management tools to support you through every stage of pregnancy. Visit mdsdiabetes.com to explore options that work with your CGM system.

πŸ“Œ Key Takeaway

In pregnant women with type 1 diabetes, CGM readings between weeks 28 and 30 showed the strongest link to high blood pressure disorders and large babies β€” suggesting this window is critical for tightening glucose control.

Important Limitations

This was a relatively small study (87 participants) at a single medical center, and it looked back at past records rather than following women forward in a controlled trial. The findings are promising but need to be confirmed in larger studies before they change standard care guidelines.

Full Citation

Fisher, Pavan, Villa-Tamayo (2026). Continuous Glucose Monitoring and Maternal and Neonatal Morbidity in Pregnant People With Type 1 Diabetes. Journal of Diabetes Science and Technology. PMID: 41186140. DOI: 10.1177/19322968251388119

References & Sources

Editorial note
This article is for educational purposes only and does not constitute medical advice. Always consult your healthcare provider before making changes to your diabetes management. Last reviewed: July 7, 2026 by the MDS Diabetes editorial team.
What to do next
πŸ“š
Read more Research articles
Explore all guides in this topic
β†’
πŸ›’
Shop related supplies at MDS
FSA/HSA eligible Β· Free shipping $60+
β†’
Topics
type 1 diabetespregnancycontinuous glucose monitoringCGMgestational healthpreeclampsiablood sugar managementresearchclinical studypeer reviewed

Related articles

Ask Mila about diabetes